TP53 and colorectal carcinoma: Although the Kaplan–Meier survival analysis between those with and without TP53 pathway alterations (Figure 2) revealed differences in early‐onset Hispanic/Latino CRC patients, the p‐value suggested that this difference was not statistically significant in overall survival.